You are here

Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Philadelphia, Pennsylvania, 19428 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Subjects
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-50 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details
Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT00783341
Pfizer
Completed
Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Healthy Subjects
NCT00705042
Males
18+
Years
Multiple Sites
Healthy Subjects
NCT03309241
All Genders
18+
Years
New Haven, Connecticut
Healthy Subjects
NCT00722501
All Genders
18+
Years
Philadelphia, Pennsylvania

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now